ArticleBlood cancer journal2011

Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo.

K Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.